Sarah Cannon Research Institute (SCRI) Oncology Partners

Nashville, Tennessee 37203

9 studies enrolling now · 9 studies all time

What they study most

Advanced Solid Tumor, Advanced Solid Tumors, Bladder Cancer, Breast Cancer, CNS Tumor, Cholangiocarcinoma, Colorectal Adenocarcinoma, Colorectal Cancer, Endometrial Cancer, Gastric / Gastroesophageal Junction Adenocarcinoma, Head and Neck Squamous Cell Carcinoma, Locally Advanced Solid Tumor

Studies at this site

• A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma (Harmony Head-to-Head) — Recruiting now
• A Study of Cemiplimab Plus Chemotherapy Versus Cemiplimab Plus Chemotherapy Plus Other Cancer Treatments for Adult Patients With Operable Non-Small Cell Lung Cancer (NSCLC) — Recruiting now
• A Study of PHST001 in Advanced Solid Tumors — Recruiting now
• A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation — Recruiting now
• FT825/ONO-8250, an Off-the-Shelf, HER2 CAR-T, With or Without Monoclonal Antibodies in Advanced Solid Tumors — Recruiting now
• A Study of ERAS-4001 in Patients With Advanced or Metastatic Solid Tumors. — Recruiting now
• ACE2016 in Adult Subjects With Locally Advanced or Metastatic Solid Tumors Expressing Epidermal Growth Factor Receptor (EGFR) — Recruiting now
• Phase 3 Study of Cadonilimab Combined With Chemotherapy vs Chemotherapy in Combination With or Without Nivolumab for the 1L Treatment of Participants With HER2-negative, Previously Untreated, Unresectable or Metastatic Gastric/GEJ Adenocarcinoma — Starting soon
• A Study of CLSP 5282 in HLA-A*03:01 Positive Adult Patients With Solid Tumors (SENTINEL-101) — Starting soon